Page last updated: 2024-08-23

phorbol 12,13-dibutyrate and Heart Disease, Ischemic

phorbol 12,13-dibutyrate has been researched along with Heart Disease, Ischemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Oriji, GK	1

Other Studies

1 other study(ies) available for phorbol 12,13-dibutyrate and Heart Disease, Ischemic

Article	Year
Adenosine induced direct negative inotropic effect is abolished during global ischemia: role of protein kinase C and prostacyclin. Prostaglandins, leukotrienes, and essential fatty acids, 2000, Volume: 63, Issue:6 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine; Animals; Depression, Chemical; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Epoprostenol; Heart Rate; Indomethacin; Male; Myocardial Contraction; Myocardial Ischemia; Perfusion; Phorbol 12,13-Dibutyrate; Prostaglandin Antagonists; Protein Kinase C; Rats; Vasodilator Agents	2000

Article

Year

Adenosine induced direct negative inotropic effect is abolished during global ischemia: role of protein kinase C and prostacyclin.

Prostaglandins, leukotrienes, and essential fatty acids, 2000, Volume: 63, Issue:6

Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine; Animals; Depression, Chemical; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Epoprostenol; Heart Rate; Indomethacin; Male; Myocardial Contraction; Myocardial Ischemia; Perfusion; Phorbol 12,13-Dibutyrate; Prostaglandin Antagonists; Protein Kinase C; Rats; Vasodilator Agents

2000